ONdrugDelivery - ONdrugDelivery - drug delivery industry specialised b2b information

STATE-OF-THE-ART SOLUTIONS FOR OPHTHALMIC STERILE DRUG PRODUCT MANUFACTURING

Swissfillon's Rainer Glöckler and Carole Delauney discuss how the company’s state-of-the-art filling line meets the requirements and complexities that are particular to ophthalmic drug product manufacturing.

THE PIVOTAL ROLE PLAYED BY DEVICE DEVELOPERS TO IMPROVE PATIENT EYE CARE

Zoë Davidson and Carolyn Rose discuss the challenges glaucoma and dry eye patients face with eye drop administration and present the Novelia^® system featuring patented PureFlow^® technology, which controls the medication flow.

DRUG DELIVERY TO THE EYE: OVERCOMING THE CHALLENGES OF INTRAVITREAL PREFILLED SYRINGES

Suresh Gupta discusses the challenges of developing a PFS product for intravitreal injection, highlighting how designing for the intravitreal space, rather than the standard parenteral, imposes a number of additional requirements on the design.

CONSIDERATIONS FOR OPHTHALMIC DRUG DELIVERY AND DEVELOPMENT

CONSIDERATIONS FOR OPHTHALMIC DRUG DELIVERY AND DEVELOPMENT

Robert Lee discusses recent advances in ophthalmic dosage forms and how companies are meeting these challenges to better serve their customers.

LINKING THE “D” & “M” IN CDMO

LINKING THE “D” & “M” IN CDMO

John Ross looks at the role of CDMOs in product development through to commercialisation and considers the benefits of consolidated “DM” models.

SPRAY CHARACTERISATION TESTING

SPRAY CHARACTERISATION TESTING

Ann Flodin introduces the company’s SprayVIEW^® measurement and automated actuation stations for the development and quality control of container closures and finished products.

ANALYTICAL TECHNIQUES FOR THE FORMULATION OF GASTRORETENTIVE TABLETS

ANALYTICAL TECHNIQUES FOR THE FORMULATION OF GASTRORETENTIVE TABLETS

Jamie Clayton, Phil Bone and Kyu Mok Hwang discuss the value of analyses such as mercury porosimetry and powder rheology in characterising excipients for gastroretentive tablet formulation, and go on to detail a case study investigating polymer excipients for a novel bilayer floating tablet.

HOSTAFORM<sup>®</sup> POM ECO-B – PROVEN, VERSATILE, EASY AND SUSTAINABLE

HOSTAFORM^® POM ECO-B – PROVEN, VERSATILE, EASY AND SUSTAINABLE

Kevin Norfleet and Rob Haley discuss the need for environmentally sustainable materials in the medical device industry, and how Celanese’s Hostaform^® MT^® POM ECO-B meets that need, being an exact equivalent to the company’s existing material but produced using up to 97% bio-content using a potential greenhouse gas as feedstock, accounted for using the mass balance approach.

I-PLATFORM DEVICE: THE SMART DEVICE WITH APTITUDE

I-PLATFORM DEVICE: THE SMART DEVICE WITH APTITUDE

Jimmy Fan outlines the capabilities and benefits of the I-Platform smart drug delivery device.

INTERVIEW WITH BENJAMIN DIETIKER, WEIDMANN MEDICAL TECHNOLOGY

Benjamin Dietiker

Weidmann Medical Technology

INTERVIEW WITH BENJAMIN DIETIKER, WEIDMANN MEDICAL TECHNOLOGY

Benjamin Dietiker, Weidmann Medical Technology, talks with ONdrugDelivery about how the company has successfully implemented a growth strategy by focusing on key areas, plans for expansion, the effect of covid-19 on the business, and how the company differentiates itself from larger competitors by focusing on quality and service.

SURFACE-MEDIATED AGGREGATION – CONTROL OF THE LIQUID-SOLID INTERFACIAL STRESS

PREFILLED SYRINGES

Glycome BioPharma

SURFACE-MEDIATED AGGREGATION – CONTROL OF THE LIQUID-SOLID INTERFACIAL STRESS

Shane Smith, Eoin Scanlan and Paula Colavita discuss how the company’s technology has evolved to create a stable and biocompatible coating that maintains device performance and safety.

ROOM FOR INNOVATION?

ROOM FOR INNOVATION?

Darren Mansell examines US FDA guidance on biosimilar interchangeability and asks whether there is room for innovation.

TOP FIVE DRUG DELIVERY TRENDS FOR 2021

TOP FIVE DRUG DELIVERY TRENDS FOR 2021

Tom Oakley provides an overview of the top five trends to expect in drug delivery in 2021.

CONSIDERATIONS FOR DEVICE SELECTION IN PARENTERAL APPLICATIONS

CONSIDERATIONS FOR DEVICE SELECTION IN PARENTERAL APPLICATIONS

Mark Tunkel looks at the challenges involved in the selection of drug devices for combination products and the optimisation of the development process.

PLATFORM TRAINING SOLUTIONS ADD VALUE FOR PHARMACEUTICAL COMPANIES

PLATFORM TRAINING SOLUTIONS ADD VALUE FOR PHARMACEUTICAL COMPANIES

Alex Catino discusses the unmet need in healthcare for proper patient onboarding and training in the field of prefilled syringes and injection devices. Ms Catino uses Noble’s training device for Ypsomed’s YpsoMate^® autoinjector as a case study for how bespoke training devices can be used to help improve the patient experience and adherence rates.

TACKLING PARENTERAL DRUG LABELLING’S SURGING COMPLEXITY

TACKLING PARENTERAL DRUG LABELLING’S SURGING COMPLEXITY

Lars Skole discusses emerging trends and challenges associated with growing parenteral packaging and labelling complexity – and how pharmaceutical developers and manufacturers can meet the challenges ahead.

INJAY: SIMPLE BY CHOICE, ADAPTABLE BY DESIGN

INJAY: SIMPLE BY CHOICE, ADAPTABLE BY DESIGN

Arnaud Guillet discusses Biocorp’s Injay solution for adding connectivity to a wide variety of PFS devices, focusing on how Injay’s designed-in simplicity and flexibility makes it easily applicable across the spectrum of PFS platforms on the market today.

NEW ENGINE FOR PRIMARY CONTAINER INJECTORS: A POWERFUL MICRO LINEAR ACTUATOR

MicroMED Co Ltd

NEW ENGINE FOR PRIMARY CONTAINER INJECTORS: A POWERFUL MICRO LINEAR ACTUATOR

Brian Li, Jiunn-Ru Lai, Tsung-Chieh Cheng, Kuang-Hsiang Cheng, Min-Ru Wang, Chia-Chi Tina Feng, and Wen-Chi Huang introduce the company’s new engine for primary container injectors, the Primary Actuator, which targets the unmet needs in the autoinjector and wearable injector market as the market shifts towards large injection volumes.

BUILDING A BETTER PREFILLED SYRINGE FOR COVID-19 VACCINE PACKAGING

PREFILLED SYRINGES

Carina Van Eester

BUILDING A BETTER PREFILLED SYRINGE FOR COVID-19 VACCINE PACKAGING

Carina Van Eester shares key learnings since the launch of the company’s NeoFlex plungers at the start of the covid-19 pandemic.

AN INCLUSIVE APPROACH TO THE DEVELOPMENT OF PLATFORM MEDICAL DEVICES

PREFILLED SYRINGES

AN INCLUSIVE APPROACH TO THE DEVELOPMENT OF PLATFORM MEDICAL DEVICES

Finola Austin discusses the difficulties presented by designing a user testing programme for platform devices when the target patient population is as yet unknown, and presents the testing framework based on seven user groups that Owen Mumford uses to meet this challenge.

BD HYLOK™ – GLASS PREFILLABLE SYRINGE FOR IV APPLICATIONS

PREFILLED SYRINGES

Sophie Trémeau

BD (Becton Dickinson & Company)

BD HYLOK™ – GLASS PREFILLABLE SYRINGE FOR IV APPLICATIONS

Sophie Trémeau, Maxime Nicolas and Myriam Leszczynski discuss BD Hylok™, a prefillable glass syringe for intravenous applications, including the rigorous testing BD Hylok™ has undergone and the regulatory support BD is able to provide to its pharmaceutical partners.

ASSESSING THE NASAL DRUG DELIVERY LANDSCAPE

ASSESSING THE NASAL DRUG DELIVERY LANDSCAPE

Jon Volmer, Jon Lenn and Professor Marc Brown discuss the role of reconstituted nasal epithelium in intranasal drug delivery.

INTERVIEW WITH STEVE AMOUSSOU-GUENOU, ROQUETTE

Steve Amoussou-Guenou

INTERVIEW WITH STEVE AMOUSSOU-GUENOU, ROQUETTE

In this interview, Steve Amoussou-Guenou discusses how Roquette developed the LYCAGEL™ system and how this plant-based alternative compares with traditional gelatin softgel capsules.

INTRODUCING ISOSORBIDE: A SUSTAINABLE, SAFE, HIGH-PERFORMANCE, PLANT-BASED FEEDSTOCK FOR PACKAGING

INTRODUCING ISOSORBIDE: A SUSTAINABLE, SAFE, HIGH-PERFORMANCE, PLANT-BASED FEEDSTOCK FOR PACKAGING

Jiae Kim introduces isosorbide, a plant starch-derived diol made from renewable feedstock that has wide ranging applications across polymer materials for a variety of industries.

MICRONEEDLES FOR INTRADERMAL DELIVERY OF CANCER VACCINES

Dr John Vasilakos

Kindeva Drug Delivery

MICRONEEDLES FOR INTRADERMAL DELIVERY OF CANCER VACCINES

John Vasilakos discusses the immuno-oncology market. He examines the role of cancer vaccines in supplementing other immuno-oncology therapies, as well as the value of delivering cancer vaccines intradermally.

AIRLESS DRUG DELIVERY: WIDELY ACCEPTED, ACCESSIBLE AND AVAILABLE

Dr Stefan Hellbardt

AIRLESS DRUG DELIVERY: WIDELY ACCEPTED, ACCESSIBLE AND AVAILABLE

Stefan Hellbardt reflects on the role of Airless technology in the dermal drug delivery market and the benefits it offers.

AN ANGLED MICRONEEDLE PATCH FOR ENHANCED DRUG AND VACCINE DELIVERY

Dr Nicky Bertollo

AN ANGLED MICRONEEDLE PATCH FOR ENHANCED DRUG AND VACCINE DELIVERY

Nicky Bertollo, Ronan Byrne and Andrew Muddle introduce Pharma Latch – a user-centric angled microneedle patch technology. They discuss its key benefits, such as dramatically increased payload potential, precision, low cost and variable patch-wear times, and highlight how Pharma Latch has the potential to overcome many of the limitations of existing routes of administration for therapeutics and vaccines.

PRODUCT SHOWCASE: Logan Instruments’ Transdermal Testing Portfolio

Logan Instruments

PRODUCT SHOWCASE: Logan Instruments’ Transdermal Testing Portfolio

Logan Instruments, a provider of laboratory instrumentation to the global pharmaceutical and cosmetics industries, with a focus on physical, dissolution and transdermal testing systems, showcases its pioneering transdermal testing system offering.

MEDICSEN: NEEDLE-FREE SMARTPATCH FOR PAINLESS DRUG DELIVERY

Dr Eduardo Jorgensen

MEDICSEN: NEEDLE-FREE SMARTPATCH FOR PAINLESS DRUG DELIVERY

Eduardo W Jørgensen, Juan César de Mercado and José Carlos Montesinos describe the Smartpatch, a novel technology for subcutaneous delivery of drugs via a comfortable, pain-free patch using sonophoresis, based on Medicsen’s patented miniaturised ultrasound technology.

RS01X – BERRY GLOBAL HEALTHCARE’S SINGLE-DOSE DPI GOES DIGITAL WITH AMIKO’S RESPIRO

Berry Global Healthcare

RS01X – BERRY GLOBAL HEALTHCARE’S SINGLE-DOSE DPI GOES DIGITAL WITH AMIKO’S RESPIRO

Mauro Citterio, Director, Marco Franza and Martijn Grinovero discuss Berry and Amiko’s partnership to develop the RS01X connected single-dose dry powder inhaler, based on Berry’s commercialised RS01 inhaler and Amiko’s Respiro digital health platform.

CONNECTED DRUG DELIVERY: ACHIEVING OPTIMAL BENEFITS THROUGH SMART COLLABORATION

CONNECTED DRUG DELIVERY: ACHIEVING OPTIMAL BENEFITS THROUGH SMART COLLABORATION

George I’ons discusses the challenges developing connected devices presents to key market stakeholders when it comes to successful rollout and implementation. Additionally, he considers the perspectives of these market players, as well as the patients themselves, with respect to how connected drug delivery devices can help them to better achieve their desired outcomes.

MEDICAL DEVICE DESIGN STRATEGY FOR A CONNECTED FUTURE

Mr Michael Kiely

Jabil Healthcare

MEDICAL DEVICE DESIGN STRATEGY FOR A CONNECTED FUTURE

Michael Kiely, Laura Marsden, Peter Stringer, and David Boyle discuss the design challenges at the electromechanical interface and encourage manufacturers to adopt a standardised approach for connecting medical devices to the cloud.

THE CHANGING FACE OF CONNECTED HEALTH IN THE TIME OF COVID-19

Phillips-Medisize

THE CHANGING FACE OF CONNECTED HEALTH IN THE TIME OF COVID-19

Neil Williams and Angela R Eder both of Phillips-Medisize, discuss how the current pandemic is transforming the adoption of connected health.

MALLYA: ENLIGHTENING PAST, EXCITING PRESENT, PROMISING FUTURE

MALLYA: ENLIGHTENING PAST, EXCITING PRESENT, PROMISING FUTURE

Arnaud Guillet reviews the Mallya connected device platform, from the origins of the project to the current success in diabetes and deployment in other fields, and introduces the promising next-generation Mallya.

D-FLEX<sup>®</sup> ECOSYSTEM – FROM DATA TO VALUE

Dr Fred Metzmann

D-FLEX^® ECOSYSTEM – FROM DATA TO VALUE

Fred Metzmann and Frank Leipold discuss the benefits of connected medical devices in clinical trials and describe the advantages of Haselmeier's D-Flex^® Ecosystem for improving adherence and reducing the dropout rate in clinical trials.

AN ADVANCED CUSTOMISABLE COMPREHENSIVE DPI CAPSULE PORTFOLIO OFFERING

Frédérique Bordes-Picard

AN ADVANCED CUSTOMISABLE COMPREHENSIVE DPI CAPSULE PORTFOLIO OFFERING

Frédérique Bordes-Picard and Julien Lamps discuss the factors driving development in the area of capsule-based dry powder inhalers, and how the company’s Capsugel^® Zephyr™ portfolio offering is perfectly positioned to meet and exceed industry’s growing and evolving requirements.

DEVELOPMENT & PRODUCTION OF RESPIMAT<sup>®</sup> REUSABLE INHALER HOUSING MODULE

DEVELOPMENT & PRODUCTION OF RESPIMAT^® REUSABLE INHALER HOUSING MODULE

Josef Schmid, Markus Müller and Nina Zielonka discuss Gerresheimer’s recent work on developing the housing module for Boehringer Ingelheim’s new version of the Respimat inhaler.

ONE-STOP SHOP FOR TOTAL MIXING SOLUTIONS FOR PHARMACEUTICAL MANUFACTURERS

INDUSTRIALISATION

Hosokawa Micron

ONE-STOP SHOP FOR TOTAL MIXING SOLUTIONS FOR PHARMACEUTICAL MANUFACTURERS

Bert Dekens discusses Hosokawa Micron's offering for pharmaceutical powder mixing, including the Cyclomix high-shear mixer and the Nauta low-shear mixer, and how the company’s technology solutions take a broader approach to the full mixing process than simply providing a mixing machine.

INTRANASAL DELIVERY OF BIOLOGIC THERAPEUTICS AND VACCINES

Intertek Melbourn

INTRANASAL DELIVERY OF BIOLOGIC THERAPEUTICS AND VACCINES

David Ward looks at how the nasal route of drug administration offers the potential to improve the delivery of biologics, even for very complex molecules such as antibodies – and why strategic formulation is required to make this a reality.

1
2
3
…
25
Next

See what ondrugdelivery's readers and contributors think

Donna Bibber
President
Micro Engineering Solutions

I picked up your latest copy at the Boston PODD event and read it with great interest. You’ve really come a long way and you put out an amazingly professional and value-packed magazine.

Dr Cristian Vilos

I‘m working on the development of microparticles for the release of veterinary antibiotics, and polymeric nanoparticles for siRNA and chemotherapeutic delivery. ONdrugDelivery has been a very usefull platform to connect the scientific research, and marketed drug development.

Li-Chun Tsou, PhD, MBA
Principal Engineer
Merck & Co

Your website and publication is a great asset for me. I’d recommend your publication to my colleagues. I am sure that we will gain knowledge and update information through your timely report. Thanks for making it available.

Abby Lockwood
Consultant
Plan Strategic

ONdrugDelivery Magazine is a great resource that brings a lot of value to the work my team and I are doing in the area of drug delivery. The device-specific content as well as the broader discussions surrounding industry trends and issues are extremely informative and very well written.

Top